0001062993-26-003123.txt : 20260609 0001062993-26-003123.hdr.sgml : 20260609 20260609153636 ACCESSION NUMBER: 0001062993-26-003123 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260609 DATE AS OF CHANGE: 20260609 EFFECTIVENESS DATE: 20260609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Thiogenesis Therapeutics, Corp. CENTRAL INDEX KEY: 0001877778 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-586737 FILM NUMBER: 261075890 BUSINESS ADDRESS: STREET 1: 4 KING STREET WEST, SUITE 401 CITY: TORONTO STATE: A6 ZIP: M5H 1B6 BUSINESS PHONE: 6478467766 MAIL ADDRESS: STREET 1: 4 KING STREET WEST, SUITE 401 CITY: TORONTO STATE: A6 ZIP: M5H 1B6 FORMER COMPANY: FORMER CONFORMED NAME: Rozdil Capital Corp DATE OF NAME CHANGE: 20210810 D 1 primary_doc.xml X0708 D LIVE 0001877778 Thiogenesis Therapeutics, Corp. 4 KING STREET WEST, SUITE 401 TORONTO A6 ONTARIO, CANADA M5H 1B6 (888) 223-9165 ONTARIO, CANADA Rozdil Capital Corp Corporation true Brook G. Riggins 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Executive Officer Director Patrice Rioux 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Executive Officer Director W. Hogan Mullally 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Director Kim Tsuchimoto 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Director Christopher Starr 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Director Biotechnology Decline to Disclose 06b false 2026-06-01 false true false 0 28964 28964 0 U.S. dollar amount is based on the Bank of Canada exchange rate of 0.7227 reported on June 1, 2026. false 0 0 0 0 false Thiogenesis Therapeutics, Corp. /s/ Brook G. Riggins Brook G. Riggins C.F.O. 2026-06-04